secwatch.observer — SEC 8-K summary
======================================

Issuer:     BillionToOne, Inc. (BLLN)
CIK:        0002070849
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0002070849-26-000029
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BillionToOne Q1 revenue $108.4M (+84% YoY), raises FY 2026 guidance to $450M-$465M
--------------------------------------------------------------------------------

- Net income $18.0M ($0.34 diluted) vs loss of $4.0M (-$0.39) in Q1 2025.
- Gross margin improved to 73% from 64% YoY; operating income $17.8M vs loss $2.3M.
- Oncology revenue surged 392% to $10.7M; prenatal revenue up 72% to $96.5M.
- Full-year 2026 revenue guidance raised to $450M-$465M from prior $430M-$445M.
- Launched Unity Confirm non-invasive confirmation assay for high-risk prenatal results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000029/0002070849-26-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000029/blln-20260506.htm
  HTML page:      https://secwatch.observer/filing/0002070849-26-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer